Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Corporate Profile for Noven Pharmaceuticals, Inc., Aug. 27, 1999.


--(BUSINESS WIRE)--

The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services. -0-

Published Date:   Aug. 27, 1999

Company Name:     Noven Pharmaceuticals, Inc.

Address:          11960 SW 144th Street
                  Miami, FL  33186

Main Telephone
 Number:          305/253-5099

Internet Home
 Page Address
  (URL)           www.noven.com

Chief Executive
 Officer:         Robert C. Strauss

Chief Financial
 Officer:         James B. Messiry

Investor Relations
 Contact:         Patricia Soper
 Business number: 305/253-1916
 E-mail address:  Psoper@noven.com

Public Relations
 Contact:         James Messiry
 Business number: 305/253-1916
 E-mail address:  jmessiry@noven.com

Industry:         Pharmaceutical

Trading Symbol/
 Exchange:        NOVN


Company description: Noven Pharmaceuticals, Inc is a leader in the development of transdermal transdermal /trans·der·mal/ (-der´m'l) entering through the dermis, or skin, as in administration of a drug via ointment or patch.

trans·der·mal
adj.
Through or by way of the skin.
 and transmucosal transmucosal /trans·mu·co·sal/ (trans?mu-ko´s'l) entering through, or across, a mucous membrane.
transmucosal,
 drug delivery technologies.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 27, 1999
Words:137
Previous Article:Crown Group to Acquire Majority Ownership of Smart Choice Automotive Group; Crown's 85%-Owned PAACO Automotive Group Subsidiary to Merge Into Smart...
Next Article:Corporate Profile for Galaxy Foods Company, Dated Aug. 27, 1999.
Topics:



Related Articles
Noven announces results for quarter ended June 30, 1995.
Noven Provides Insight Regarding Third Quarter Expectations.
Noven Announces Record Financial Results.
Noven Announces Record Financial Results; Net Income Up 262% Over 1999 Second Quarter; Quarterly Revenues Increase 40% Over Prior Year Period.
Noven Announces Record Financial Results.
Noven to Announce 2000 Financial Results On February 26.
Professor Regina E. Herzlinger Joins Noven Pharmaceuticals' Board of Directors.
Wayne Yetter Joins Noven's Board Of Directors; Pharmaceutical Industry Veteran Appointed to Noven Board.
Noven's Chief Technical Officer to Present At Novartis Menopause Symposium; Noven's Juan Mantelle to Address History and Science of Transdermal Drug...
Cauley Geller Bowman & Coates LLP Announces Class Action Lawsuit Against Noven Pharmaceuticals Inc.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles